South Dakota Faces Implementation Questions After Cannabis Rescheduling

280E Tax Penalty Eliminated for State-Licensed Operators

The rescheduling removes Internal Revenue Code Section 280E, which barred cannabis businesses from deducting ordinary expenses like payroll, rent, and utilities. South Dakota's 68 licensed dispensaries operated under effective tax rates exceeding 70 percent before the change, according to state revenue data. Under Schedule III, medical cannabis businesses can now file standard corporate tax returns and claim deductions identical to any pharmacy or retail operation.

The shift doesn't reduce the federal excise tax rate. Cannabis remains subject to standard corporate income tax. But it restores the ability to deduct cost of goods sold and operating expenses. For a dispensary with $2 million in annual revenue and $1.2 million in operating costs, the change could reduce federal tax liability by approximately $350,000 annually, based on a 35 percent marginal rate.

South Dakota collected $4.8 million in state sales tax from medical cannabis in fiscal year 2025. The state's 4.5 percent sales tax on medical cannabis remains unchanged by federal rescheduling, and the Department of Revenue has confirmed that state tax obligations are unaffected by the DEA's action.

Banking Access Opens Under Schedule III Framework

Federal rescheduling allows banks and credit unions to service cannabis businesses without triggering Bank Secrecy Act violations or FinCEN Suspicious Activity Report requirements. Before the change, South Dakota dispensaries operated almost entirely in cash due to federal money-laundering statutes that classified cannabis proceeds as illegal funds. Only three state-chartered credit unions provided limited services to the industry under FinCEN's 2014 Cole Memo guidance, which the Trump administration rescinded in 2018.

First Dakota National Bank announced on August 15, 2026, that it would begin offering checking accounts, merchant services, and commercial loans to state-licensed medical cannabis operators. The bank's statement specified that services are available only to businesses holding valid South Dakota Department of Health dispensary licenses and operating in compliance with state law. Two additional regional banks have indicated they're reviewing policies but haven't committed to timelines.

The South Dakota Bankers Association hasn't issued formal guidance to member institutions. Association president Tom Harold said in an email that banks are awaiting clarification from federal regulators on whether anti-money-laundering obligations differ for Schedule III substances compared to Schedule I or II.

State Regulators Lack Federal Compliance Roadmap

South Dakota's Department of Health hasn't published guidance on whether dispensaries must meet DEA registration requirements or FDA labeling standards to maintain state licenses. The department's August 16 statement acknowledged the rescheduling but deferred questions about federal compliance to the DEA and FDA. State law doesn't reference federal scheduling status as a licensing criterion, creating ambiguity about whether operators must now register with the DEA as handlers of a Schedule III controlled substance.

DEA registration for Schedule III substances typically requires facilities to meet security, recordkeeping, and inventory-control standards outlined in 21 CFR Part 1301. South Dakota's existing regulations mandate video surveillance, alarm systems, and daily inventory reconciliation, but those rules were written before rescheduling and don't explicitly reference DEA registration pathways. The department has scheduled a stakeholder meeting for September 5, 2026, to discuss potential regulatory updates.

No state-licensed dispensary has applied for DEA registration as of August 17, according to publicly available DEA records. The application process requires a state-issued controlled-substance license, which South Dakota doesn't currently issue for cannabis. The Department of Health hasn't indicated whether it will create a new license category or amend existing dispensary licenses to satisfy DEA prerequisites.

Interstate Commerce Remains Prohibited Despite Schedule Change

Rescheduling to Schedule III doesn't authorize interstate cannabis commerce, leaving South Dakota's supply chain confined to in-state cultivation and processing. Federal law still prohibits transporting cannabis across state lines, even between states with legal medical programs. South Dakota's 12 licensed cultivation facilities supply the state's dispensaries under a closed-loop system that tracks plants from seed to sale using the state's Metrc inventory platform.

This restriction prevents South Dakota operators from accessing lower-cost wholesale markets in states like Oklahoma or Michigan, where oversupply has driven wholesale flower prices below $200 per pound. South Dakota wholesale prices averaged $1,850 per pound in July 2026, according to state transaction data. Operators have requested that the legislature authorize interstate commerce if federal law changes, but no bill has been introduced.

The FDA hasn't issued guidance on whether Schedule III cannabis products require New Drug Applications or abbreviated approval pathways. South Dakota dispensaries currently sell flower, tinctures, edibles, and topicals under state labeling rules that mandate THC content disclosure and child-resistant packaging. If the FDA asserts jurisdiction over Schedule III cannabis as a drug rather than a supplement, existing products could face compliance gaps.

Patient Access and Pricing Impact Uncertain

Tax and banking changes are expected to reduce operating costs for dispensaries, but it's unclear whether savings will translate to lower patient prices. South Dakota's medical cannabis program served 8,742 registered patients as of July 31, 2026. The average patient spends $220 per month on cannabis products, based on state sales data. Dispensary operators haven't announced price reductions following the rescheduling.

Industry representatives said cost savings from 280E repeal will first offset losses from prior years when effective tax rates exceeded 70 percent. Several dispensaries reported net losses in 2024 and 2025 due to the tax burden, and operators are prioritizing debt repayment and reserve-building before adjusting retail prices. One Sioux Falls dispensary owner, speaking on condition of anonymity, estimated that it would take 18 to 24 months to recover from prior-year losses even with the new tax treatment.

Patient advocates have called on the state to reduce the $200 annual registration fee and expand qualifying conditions to include chronic pain and PTSD. The Department of Health hasn't indicated whether it will revisit the fee structure or condition list in light of federal rescheduling. The state's medical cannabis law, passed by voter initiative in 2020, doesn't tie qualifying conditions to federal scheduling status.

What Operators and Regulators Are Watching Next

The September 5 stakeholder meeting will address whether South Dakota will require DEA registration, adopt FDA labeling rules, or maintain the current state-only framework. The Department of Health has invited dispensary operators, cultivation facilities, physicians, and patient advocates to submit written comments by August 30. Key questions include whether the state will create a pathway for DEA registration, how existing licenses will be amended, and whether interstate commerce will be revisited if federal law evolves further.

Banks are waiting for the Federal Reserve and FDIC to issue formal guidance on Schedule III cannabis accounts. While rescheduling removes the core legal barrier, banks still face reputational risk and uncertainty about anti-money-laundering standards. The South Dakota Bankers Association has scheduled a members-only briefing for August 28 to review compliance considerations.

For full background on the federal rescheduling process, see the CannIntel topic hub on DEA rescheduling. The rescheduling took effect on August 1, 2026, following a final rule published in the Federal Register on July 15. South Dakota's regulatory response remains unsettled, and operators should expect enforcement guidance to vary as state agencies interpret the intersection of federal and state law.